Compound information
- Natural Products
- ZC674035
- Molecular Formula
- C17H24N2O6S
- Molecular Weight
- 384.135507488 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(4-methoxycarbonylphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C17H24N2O6S/c1-17(2,3)25-16(21)18-9-11-19(12-10-18)26(22,23)14-7-5-13(6-8-14)15(20)24-4/h5-8H,9-12H2,1-4H3
- InChI Key
- JEFLDVXIWBKZRU-UHFFFAOYSA-N
- SMILES
- COC(=O)c1ccc(S(=O)(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1
- Source
- ZINC000034492131
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 93.22 Å2 | LogP | 2.433 |
LogS | -3.66 | LogD | 3.195 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.05 | Pgp substrate | 0.022 |
HIA | 0.968 | F20 % | 0.573 |
F30 % | 0.729 | Caco-2 | -4.487 |
MDCK | -4.854 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.225 | PPB | 82.185 |
VD | 1.589 | Fu | 0.663 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.183 | CYP1A2 substrate | 0.38 |
CYP2A6 substrate | 0.515 | CYP2B6 substrate | 0.603 |
CYP2C19 inhibitor | 0.809 | CYP2C19 substrate | 0.739 |
CYP2C8 substrate | 0.525 | CYP2C9 inhibitor | 0.494 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.059 |
CYP2D6 substrate | 0.622 | CYP2E1 substrate | 0.483 |
CYP3A4 inhibitor | 0.058 | CYP3A4 substrate | 0.994 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.473 | CL | 6.979 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.884 | Hepatotoxicity | 0.722 |
Mutagenicity | 0.217 | Rat Oral Acute Toxicity | 0.027 |
FDAMDD | 0.036 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.054 | Eye Corrosion | 0.001 |
Eye Irritation | 0.02 | Respiratory Toxicity | 0.025 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.919 | IGC50 | 3.464 |
LC50FM | 2.35 | LC50DM | 1.812 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.364 | NR-AR-LBD | 0.252 |
NR-AhR | 0.032 | NR-Aromatase | 0.034 |
NR-ER | 0.295 | NR-ER-LBD | 0.461 |
NR-PPAR-gamma | 0.1 | SR-ARE | 0.444 |
SR-ATAD5 | 0.398 | SR-HSE | 0.053 |
SR-MMP | 0.015 | SR-p53 | 0.025 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.